Uncertain Markets Boost Case for Defensive Healthcare Dividend Stocks

In uncertain markets driven by sticky July PCE inflation and a divided Federal Reserve, investors may find steady dividend income from companies in defensive sectors. Three such stocks are Abbott Laboratories (ABT), Elevance Health (ELV), and UnitedHealth Group (UNH). These healthcare giants offer a mix of recurring cash flows, dividends, and newer products.

Abbott Laboratories is a global healthcare company with a diversified portfolio, including medical devices, diagnostic systems, branded generics, and nutrition products. Its size and diversification can help soften the blow from pockets of pressure such as margin compression, higher debt, and pricing pressure in diagnostics and emerging markets.

Elevance Health provides health benefits through brands like Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon. It generates most of its revenue in the United States, with about $169.3 billion from Health Benefits. The company's 1.71% dividend is attractive relative to some peers, but thin net margins around 2.5% pose a risk.

UnitedHealth Group is a global health care company built around two pillars: UnitedHealthcare insurance plans and the Optum services businesses. Its role as a large, diversified U.S. health insurer with a dividend history fits the High-Quality Dividend Stocks in Defensive Sectors theme, giving investors exposure to healthcare spending that often proves steadier than more cyclical sectors.